Literature DB >> 28386622

Probucol attenuates overt pain-like behavior and carrageenan-induced inflammatory hyperalgesia and leukocyte recruitment by inhibiting NF-кB activation and cytokine production without antioxidant effects.

Amanda Z Zucoloto1, Marília F Manchope1, Larrisa Staurengo-Ferrari1, José C Alves-Filho2, Thiago M Cunha2, Maísa M Antunes3, Gustavo B Menezes3, Fernando Q Cunha2, Rubia Casagrande4, Waldiceu A Verri5.   

Abstract

OBJECTIVE AND
DESIGN: This study aimed to evaluate the effect of probucol in inflammatory hyperalgesia and leukocyte recruitment in mice. TREATMENT: Probucol at 0.3-3 mg/kg was administrated per oral 1 h before inflammatory stimulus.Author: Kindly check and confirm the affiliation 1 have been correctly processed or not and amend if necessary.Thank you. We have corrected affiliation 1. We added the information to the appropriate boxes. However the state and the postal code are in a different order when compared to the other affiliations.
METHODS: Overt pain-like behaviors were determined by the number of abdominal writhings induced by phenyl-p-benzoquinone and acetic acid. Mechanical and thermal hyperalgesia induced by carrageenan were determined using an electronic anesthesiometer and hot plate apparatus, respectively. Leukocyte recruitment was evaluated by direct count or by determination of myeloperoxidase and N-acetylglucosaminidase activities. Antioxidant ability was determined by measurement of GSH levels, ABTS and FRAP assays. Cytokine production and NF-кB activation were evaluated by ELISA. Data were analyzed by ANOVA followed by Tukey's post-hoc. p < 0.05 was considered significant.
RESULTS: Probucol reduced overt pain-like behavior, and carrageenan-induced mechanical and thermal hyperalgesia. These effects were accompanied by reduced leukocyte influx in both paw skin and peritoneum exudate. Probucol did not alter carrageenan-induced tissue antioxidant capacity at anti-inflammatory/analgesic dose. On the other hand, probucol inhibited carrageenan-induced IL-1β, TNF-α and CXCL1 production as well as NF-кB activation.
CONCLUSION: Probucol presents analgesic and anti-inflammatory activities by employing mechanisms other than its antioxidant properties. These mechanisms involve targeting of pro-inflammatory cytokines and NF-кB activation.

Entities:  

Keywords:  Acute inflammation; Carrageenan; Pain; Probucol

Mesh:

Substances:

Year:  2017        PMID: 28386622     DOI: 10.1007/s00011-017-1040-8

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  66 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

2.  Probucol inhibits neointimal formation in carotid arteries of normocholesterolemic rabbits and the proliferation of cultured rabbit vascular smooth muscle cells.

Authors:  K Tanaka; K Hayashi; T Shingu; Y Kuga; K Nomura; G Kajiyama
Journal:  Cardiovasc Drugs Ther       Date:  1998-03       Impact factor: 3.727

3.  Impaired inflammatory angiogenesis, but not leukocyte influx, in mice lacking TNFR1.

Authors:  L S Barcelos; A Talvani; A S Teixeira; L Q Vieira; G D Cassali; S P Andrade; M M Teixeira
Journal:  J Leukoc Biol       Date:  2005-05-13       Impact factor: 4.962

4.  Inhibition by probucol of interleukin 1 secretion and its implication in atherosclerosis.

Authors:  G Ku; N S Doherty; J A Wolos; R L Jackson
Journal:  Am J Cardiol       Date:  1988-07-25       Impact factor: 2.778

5.  Antinociceptive effect of meloxicam, in neurogenic and inflammatory nociceptive models in mice.

Authors:  A R Santos; E M Vedana; G A De Freitas
Journal:  Inflamm Res       Date:  1998-07       Impact factor: 4.575

6.  Ginkgo biloba extract inhibits tumor necrosis factor-alpha-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells.

Authors:  Jaw-Wen Chen; Yung-Hsiang Chen; Feng-Yan Lin; Yuh-Lien Chen; Shing-Jong Lin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-07-31       Impact factor: 8.311

7.  Nociceptors are interleukin-1beta sensors.

Authors:  Alexander M Binshtok; Haibin Wang; Katharina Zimmermann; Fumimasa Amaya; Daniel Vardeh; Lin Shi; Gary J Brenner; Ru-Rong Ji; Bruce P Bean; Clifford J Woolf; Tarek A Samad
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

8.  Inhibition of IL-1 beta expression in THP-1 cells by probucol and tocopherol.

Authors:  A L Akeson; C W Woods; L B Mosher; C E Thomas; R L Jackson
Journal:  Atherosclerosis       Date:  1991-02       Impact factor: 5.162

9.  Netrin-1 regulates the inflammatory response of neutrophils and macrophages, and suppresses ischemic acute kidney injury by inhibiting COX-2-mediated PGE2 production.

Authors:  Punithavathi V Ranganathan; Calpurnia Jayakumar; Riyaz Mohamed; Zheng Dong; Ganesan Ramesh
Journal:  Kidney Int       Date:  2013-02-27       Impact factor: 10.612

10.  Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits.

Authors:  Manabu Niimi; Yuka Keyamura; Masanori Nozako; Takashi Koyama; Masayuki Kohashi; Reiko Yasufuku; Tomohiro Yoshikawa; Jianglin Fan
Journal:  Lipids Health Dis       Date:  2013-11-04       Impact factor: 3.876

View more
  2 in total

1.  From Initiation to Maintenance: HIV-1 Gp120-induced Neuropathic Pain Exhibits Different Molecular Mechanisms in the Mouse Spinal Cord Via Bioinformatics Analysis Based on RNA Sequencing.

Authors:  Jian Huang; Fei Lin; Yanling Hu; Chris Bloe Bloe; Dan Wang; Wenping Zhang
Journal:  J Neuroimmune Pharmacol       Date:  2022-01-21       Impact factor: 4.147

2.  Effect of nanostructured lipid carriers on transdermal delivery of tenoxicam in irradiated rats.

Authors:  Saud Bawazeer; Dalia Farag A El-Telbany; Majid Mohammad Al-Sawahli; Gamal Zayed; Ahmed Abdallah A Keed; Abdelaziz E Abdelaziz; Doaa H Abdel-Naby
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.